Thank you to Reviewers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 519, doi. 10.1177/1078155219827481
- Publication type:
- Article
Works matching IS 10781552 AND DT 2019 AND VI 25 AND IP 3
Results: 39
1
2
Nonallergic cutaneous pigmentation is commonly observed after methotrexate administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 769, doi. 10.1177/1078155218815557
- By:
- Publication type:
- Article
3
Updates and novel treatments in urothelial carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 648, doi. 10.1177/1078155218805141
- By:
- Publication type:
- Article
4
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 638, doi. 10.1177/1078155218799850
- By:
- Publication type:
- Article
5
Preservation of cognitive function following whole brain radiotherapy in patients with brain metastases: Complications, treatments, and the emerging role of memantine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 657, doi. 10.1177/1078155218798176
- By:
- Publication type:
- Article
6
Thiotepa-induced cutaneous toxicity in pediatric patients: Case report and implementation of preventive care guidelines.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 689, doi. 10.1177/1078155218796905
- By:
- Publication type:
- Article
7
Penetrating the evidence of EGFR and ALK tyrosine kinase inhibitors for non-small cell lung cancer brain metastases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 623, doi. 10.1177/1078155218796695
- By:
- Publication type:
- Article
8
Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 674, doi. 10.1177/1078155218796182
- By:
- Publication type:
- Article
9
Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 613, doi. 10.1177/1078155218788706
- By:
- Publication type:
- Article
10
To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 663, doi. 10.1177/1078155218786365
- By:
- Publication type:
- Article
11
Can clinical pharmacists bridge a gap between medical oncologists and patients in resource-limited oncology settings? An experience in Nepal.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 765, doi. 10.1177/1078155218784734
- By:
- Publication type:
- Article
12
Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 762, doi. 10.1177/1078155218771152
- By:
- Publication type:
- Article
13
In case of anastrozole-related hallucinations, can switching to letrozole be a treatment option? A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 754, doi. 10.1177/1078155218762626
- By:
- Publication type:
- Article
14
Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 747, doi. 10.1177/1078155218762624
- By:
- Publication type:
- Article
15
Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 724, doi. 10.1177/1078155217752537
- By:
- Publication type:
- Article
16
Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 739, doi. 10.1177/1078155218760160
- By:
- Publication type:
- Article
17
Adverse events associated with aprepitant pediatric bone cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 735, doi. 10.1177/1078155218755547
- By:
- Publication type:
- Article
18
Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 731, doi. 10.1177/1078155217754244
- By:
- Publication type:
- Article
19
Dasatinib-induced pulmonary arterial hypertension – A rare late complication.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 727, doi. 10.1177/1078155217753740
- By:
- Publication type:
- Article
20
Verapamil as a culprit of palbociclib toxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 743, doi. 10.1177/1078155218761798
- By:
- Publication type:
- Article
21
Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 719, doi. 10.1177/1078155217752536
- By:
- Publication type:
- Article
22
Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 607, doi. 10.1177/1078155217752534
- By:
- Publication type:
- Article
23
Aplastic anemia secondary to propylthiouracil: A rare and life-threatening adverse effect.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 715, doi. 10.1177/1078155217752079
- By:
- Publication type:
- Article
24
Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 710, doi. 10.1177/1078155217752078
- By:
- Publication type:
- Article
25
Systemic anticancer therapy in the last 30 days of life: Retrospective audit from an Australian Regional Cancer Centre.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 599, doi. 10.1177/1078155217752077
- By:
- Publication type:
- Article
26
Implementation of additional prescribing authorization among oncology pharmacists in Alberta.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 584, doi. 10.1177/1078155217752076
- By:
- Publication type:
- Article
27
The value of fixed rasburicase dosing versus weight-based dosing in the treatment and prevention of tumor lysis syndrome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 577, doi. 10.1177/1078155217752075
- By:
- Publication type:
- Article
28
Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 758, doi. 10.1177/1078155217752074
- By:
- Publication type:
- Article
29
Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 706, doi. 10.1177/1078155217750463
- By:
- Publication type:
- Article
30
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 703, doi. 10.1177/1078155217748471
- By:
- Publication type:
- Article
31
Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 567, doi. 10.1177/1078155217748470
- By:
- Publication type:
- Article
32
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 699, doi. 10.1177/1078155217745710
- By:
- Publication type:
- Article
33
Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 558, doi. 10.1177/1078155217745145
- By:
- Publication type:
- Article
34
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 551, doi. 10.1177/1078155217745144
- By:
- Publication type:
- Article
35
Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 544, doi. 10.1177/1078155217744872
- By:
- Publication type:
- Article
36
A retrospective analysis of clinical acuity markers on hospital length of stay in patients with febrile neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 535, doi. 10.1177/1078155217744379
- By:
- Publication type:
- Article
37
Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 694, doi. 10.1177/1078155217743565
- By:
- Publication type:
- Article
38
Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 529, doi. 10.1177/1078155217743074
- By:
- Publication type:
- Article
39
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 520, doi. 10.1177/1078155217740945
- By:
- Publication type:
- Article